F-star Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FSTX and buy or sell other stocks, ETFs, and their options commission-free!About FSTX
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.
CEONeil Brewis, PhD
CEONeil Brewis, PhD
Employees—
Employees—
HeadquartersCambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded2002
Founded2002
Employees—
Employees—
FSTX Key Statistics
Market cap156.51M
Market cap156.51M
Price-Earnings ratio-3.44
Price-Earnings ratio-3.44
Dividend yield—
Dividend yield—
Average volume1.24M
Average volume1.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.12
52 Week high$7.12
52 Week low$2.07
52 Week low$2.07
Stock Snapshot
As of today, F-star Therapeutics(FSTX) shares are valued at $7.12. The company's market cap stands at 156.51M, with a P/E ratio of -3.44.
On 2026-04-27, F-star Therapeutics(FSTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.24M.
The stock's 52-week range extends from a low of $2.07 to a high of $7.12.
The stock's 52-week range extends from a low of $2.07 to a high of $7.12.
People also own
Based on the portfolios of people who own FSTX. This list is generated using Robinhood data, and it’s not a recommendation.